Here's what to expect this week on Diagnostic Imaging.
In this week’s preview, here are some highlights of what you can expect to see coming soon:
Last week, the U.S. Preventive Services Task Force release their plan for how they will craft the next breast screening guidelines. This week, Diagnostic Imaging takes a look at industry response the announcement and what providers think should factor into creating recommendations around this essential service for women.
For additional coverage on breast screening guidelines, click here.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
In the last 30 years, the incidence of thyroid cancer has rising dramatically, making effective imaging critical to identifying patients who have developed this condition and treating them as early as possible. This week, Diagnostic Imaging will speak with Erin Grady, M.D., associate professor and director nuclear medicine education at Emory University School of Medicine, about the latest in molecular imaging and therapy. Look for coverage later this week.
For additional articles on thyroid cancer, click here.
Gender equality has been a hot topic in radiology for decades as efforts are constantly improving to bring more women into the specialty and break down barriers that prevent career advancement. But, gender discrimination and sexual harassment are still a significant problem. This week, Diagnostic Imaging takes a look at the current state of this problem, highlighting some strategies that various institutions have taken to address these issues.
For additional coverage of gender issues in radiology, click here.
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.